PATH vs SPRB
Uipath Inc (PATH) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the PATH and SPRB stock pages for the full models.
Not investment advice.